Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Preferred Stock Liabilities (2020 - 2021)

NeuroPace has reported Preferred Stock Liabilities over the past 2 years, most recently at $141.4 million for Q1 2021.

  • Quarterly results put Preferred Stock Liabilities at $141.4 million for Q1 2021, up 92.23% from a year ago — trailing twelve months through Mar 2021 was $141.4 million (up 92.23% YoY), and the annual figure for FY2020 was $141.4 million, changed.
  • Preferred Stock Liabilities for Q1 2021 was $141.4 million at NeuroPace, roughly flat from $141.4 million in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for NPCE hit a ceiling of $141.4 million in Q3 2020 and a floor of $73.5 million in Q2 2020.